| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160831 Pyrrolopyrimidinone derivatives |
| 07/20/2006 | US20060160830 3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 07/20/2006 | US20060160829 Thienopyrimidine compounds and use thereof |
| 07/20/2006 | US20060160828 Amino-imidazolones for the inhibition of beta-secretase |
| 07/20/2006 | US20060160827 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith |
| 07/20/2006 | US20060160826 Methods of treating ischemic related conditions |
| 07/20/2006 | US20060160825 1-(5-Benzenesulfonyl-indan-1-yl)-piperazine, used as selective serotonin receptor antagonists for treatment of nervous system and gastrointestinal disorders |
| 07/20/2006 | US20060160824 Indole derivatives as serotonin reuptake inhibitors |
| 07/20/2006 | US20060160823 Particulate-stabilized injectable pharmaceutical compositions of Posaconazole |
| 07/20/2006 | US20060160822 Method of Using Flibanserin for Neuroprotection |
| 07/20/2006 | US20060160821 N-[4-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenyl]-2-(4-chlorophenylaminocarbonylamino)-acetamide; thrombosis prevention |
| 07/20/2006 | US20060160820 Substituted piperazine carbamates |
| 07/20/2006 | US20060160819 Substitued piperazine carbamates |
| 07/20/2006 | US20060160818 Ocular hypotensive agent |
| 07/20/2006 | US20060160817 4-phenylpyrimidine compounds such as 4-(2-Fluoro-phenyl)-2-morpholin-4-yl-pyrimidine-5-carboxylic acid benzyl-isopropyl-amide, useful as inhibitors of voltage-gated sodium channels and/or calcium channels, for the treatment of pain, psychological and neurodegenerative disorders |
| 07/20/2006 | US20060160816 Pirazino(AZA) indole derivatives |
| 07/20/2006 | US20060160815 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents |
| 07/20/2006 | US20060160814 Phosphodiesterase 10 inhibitors |
| 07/20/2006 | US20060160813 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis |
| 07/20/2006 | US20060160812 1-Substituted-3,5-distyrylpyrazoles; protect neurons and promote neuroregeneration and memory formation; treatments for acute neural injuries (such as stroke and spinal cord injury) and chronic neurodegenerative diseases |
| 07/20/2006 | US20060160811 Aryl-condensed 3-arylpridine compounds and use thereof for controlling pathogenic fungi |
| 07/20/2006 | US20060160810 2-Alkoxyphenyl substituted imidazotriazinones |
| 07/20/2006 | US20060160809 Diseases which respond to influencing by dopamine D3 receptor antagonists or agonists, diseases of the central nervous system and disturbances of kidney function; N-[6-(4-Allylpiperazin-1-yl)pyridin-3-yl]-4-isopropylbenzenesulfonamide |
| 07/20/2006 | US20060160808 New carboxylic acid derivatives, their preparation and their use |
| 07/20/2006 | US20060160807 mitogen-activated protein (MAP) kinase inhibitor; antiproliferative, anticarcinogenic agent; autoimmune disorders; |
| 07/20/2006 | US20060160806 N-benzyl-N'-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea |
| 07/20/2006 | US20060160805 Thiotungstate analogues and uses thereof |
| 07/20/2006 | US20060160804 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 07/20/2006 | US20060160803 Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity |
| 07/20/2006 | US20060160802 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide |
| 07/20/2006 | US20060160801 Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 07/20/2006 | US20060160800 Morpholino-2-[6-(2-Ethoxy-phenyl)-pyridin-3-yl]-benzyl)-acetamide compound; as anti-proliferative agents, for treating mammals |
| 07/20/2006 | US20060160799 Benzimidazoles for reducing antibiotic resistance of cells and inhibition of biofilms |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/20/2006 | US20060160796 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases |
| 07/20/2006 | US20060160795 Administering benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, extracted from immature corn plants, in oral, parenteral, sustained release or transdermal dosage forms; fibromyalgia, sleep apnea; hypoglycemic, antidiabetic and antiarthritic agents |
| 07/20/2006 | US20060160794 Such as [1-(3,5-bis-trifluoromethylbenzyl)-5-imidazol-1-yl-1H-[1,2,3]triazol-4-yl]-[5-(2-chlorophenyl)-3-hydroxymethyl-isoxazol-4-yl]-methanone; for treatment of depression, anxiety, irritable bowel syndrome, and emesis |
| 07/20/2006 | US20060160793 Synergistic inhibition of aggregation and inflammation in vessel walls |
| 07/20/2006 | US20060160792 taurolidine or taurultam; inhibiting growth of a tumor cell |
| 07/20/2006 | US20060160790 Thioureas as factor Xa inhibitors |
| 07/20/2006 | US20060160789 Use of pharmacological compounds for the prevention or treatment of acute tolerance to morphines |
| 07/20/2006 | US20060160788 such as Rac-(2-isopropoxy-5-methanesulfonyl-phenyl)-[3-(4-trifluoromethyl-phenoxy)-pyrrolidin-1-yl]-methanone, having good glycine transporter inhibitory activity and useful for the treatment of nervous system disorders such as schizophrenia, cognitive impairment and Alzheimer's disease |
| 07/20/2006 | US20060160787 for example 1-(methylthio)-3-methoxy-4-(2-fluorophenyl)azetidin-2-one; induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation |
| 07/20/2006 | US20060160786 e.g. 5-[3-[4-(3-fluoro-2-methylphenoxy)piperidin-1-yl]-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl]-2-methoxypyridine; treatment of arousal disorder, orgasmic disorder, sexual pain disorder and premature ejaculation, preterm labor, appetite and feeding disorders, dysmenorrhoea, congestive heart failure |
| 07/20/2006 | US20060160785 Ezetimibe polymorphs |
| 07/20/2006 | US20060160784 Method for treating neurologic diseases |
| 07/20/2006 | US20060160783 Novel omeprazole forms and related methods |
| 07/20/2006 | US20060160782 2-Substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 07/20/2006 | US20060160781 A conjugated compound with triamcinolone acetonide; Antiinflammatory agents; immunosuppressants |
| 07/20/2006 | US20060160780 A conjugated compound with prednicarbate; Antiinflammatory agents; immunosuppressants |
| 07/20/2006 | US20060160779 2,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin d derivative |
| 07/20/2006 | US20060160778 recognize and bind the tubulin site: antitubulin; useful for treating pathological states which arise from or are exacerbated by cell proliferation as anticancer and/or antiangiogenic activity |
| 07/20/2006 | US20060160777 New use of GABAbeta receptor agonists |
| 07/20/2006 | US20060160776 Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damage |
| 07/20/2006 | US20060160775 synergistic mixture of 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline and N-acetylcolchinol-O-phosphate, for the treatment of cancers; angiogenesis inhibitors and vascular permeability reducing effect in mammals |
| 07/20/2006 | US20060160774 Useful in assisting in the polymerization of monomers in a free radical polymerization that has living-type kinetics |
| 07/20/2006 | US20060160773 Combretastatin derivatives with cytotoxic action |
| 07/20/2006 | US20060160772 Process for manufacture of fosinopril sodium |
| 07/20/2006 | US20060160771 Aminophosphonic acid derivatives, addition salts thereof and sip receptor modulators |
| 07/20/2006 | US20060160770 Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds |
| 07/20/2006 | US20060160769 And protected derivatives; arrests the proliferation of undifferentiated cells and induces their differentiation to monocytes; treating cancer, skin disorders, autoimmune disorders, inflammatory conditions, obesity and renal osteodystrophy |
| 07/20/2006 | US20060160768 Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 07/20/2006 | US20060160767 Method of providing food product with prolonged energy release |
| 07/20/2006 | US20060160766 Therapy-enhancing glucan |
| 07/20/2006 | US20060160765 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 07/20/2006 | US20060160764 LIMKs as modifiers of p53 pathway and methods of use |
| 07/20/2006 | US20060160756 Treatment and prevention of multi-drug resistance |
| 07/20/2006 | US20060160755 Neoadjuvant treatment of breast cancer |
| 07/20/2006 | US20060160754 Glycyrrhizin high-concentration preparation |
| 07/20/2006 | US20060160753 Micronutrient formulation for cognitive & mood benefits |
| 07/20/2006 | US20060160752 Promoter for the production of hyaluronic acid containing ginsenoside compound k |
| 07/20/2006 | US20060160751 dihydrofolate reductase inhibitors |
| 07/20/2006 | US20060160750 Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss |
| 07/20/2006 | US20060160748 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 07/20/2006 | US20060160746 Amino acid and peptide conjugates of amiloride and methods of use thereof |
| 07/20/2006 | US20060160739 GRF-containing lyophilized pharmaceutical compositions |
| 07/20/2006 | US20060160736 Pharmaceutical compositions and methods for restoring beta-cell mass and function |
| 07/20/2006 | US20060160731 Peptide nucleic acids |
| 07/20/2006 | US20060160721 Method of plasma lipidation to prevent, inhibit and/or reverse atherosclerosis |
| 07/20/2006 | US20060160213 Enhancement of mammalian embryo development |
| 07/20/2006 | US20060160203 Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
| 07/20/2006 | US20060160201 Three-dimensional structures of HDAC9 and Cabin1 and compound structures and methods related thereto |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060160154 Materials and methods for detection and treatment of breast cancer |
| 07/20/2006 | US20060160119 Genetic screening for improving treatment of patients diagnosed with depression |
| 07/20/2006 | US20060160079 Methods for the treatment of dementia based on apo e genotype |
| 07/20/2006 | US20060159790 Composition for preventing or treating dementia comprising a hydroxycinnamic acid derivative or an extract of a plant of genus angelicae containing same |
| 07/20/2006 | US20060159788 Indian mulberry plant extract comprising fruit juice, oil, quercetin, puree juice and dietary fiber components; antimicrobial activity; yeast infections |
| 07/20/2006 | US20060159783 Method for treating cancer using betulinic acid rich herbal extract |
| 07/20/2006 | US20060159782 Material for promoting skin basement formation |
| 07/20/2006 | US20060159781 Plant extract as anticancer agents |
| 07/20/2006 | US20060159779 treating Type II diabetes by administering a foodstuff or beverage containing a dried extract of a plant of the genus Hoodia; trigyleride; 3-0-[-.beta.-D-thevetopyranosyl-(1-4)-.beta.-D-cymaropyranosyl-(1-4)-.beta.-D-cymaropyranosyl]-12.beta.-0-tigloyloxy-14-hydroxy-14.beta.-pregn-50-ene-20-one |
| 07/20/2006 | US20060159778 Method of treatment and prophylaxis of people's adiposity |
| 07/20/2006 | US20060159776 Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases |
| 07/20/2006 | US20060159773 Herbal compositions containing hoodia |
| 07/20/2006 | US20060159771 Heavy water, a glycosaminoglycan such as chondroitin sulfate; administering to the vitreous cavity of the eye for retinal repair |
| 07/20/2006 | US20060159770 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 07/20/2006 | US20060159768 Quetiapine granules |